Amelia Altavilla
Meldola, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 26, 2024
Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study.
Journal: iScience
Published: February 06, 2024
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study.
Journal: European urology open science
Published: January 25, 2024
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer.
Journal: The oncologist
Published: June 19, 2023
Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical Practice.
Journal: Frontiers in oncology
Published: January 21, 2022
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome.
Journal: Molecular oncology
Published: June 11, 2021
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma.
Journal: Frontiers in oncology
Published: May 28, 2021
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer.
Journal: Expert opinion on pharmacotherapy
Published: August 14, 2020
Last Updated: 09/26/2026